Clinical Trial Update: Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 safety study results for CC-93538 in adult and adolescent participants with eosinophilic esophagitis; results were posted on 2026-04-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• CC-93538

Snippet

Sponsor: Celgene | Conditions: Eosinophilic Esophagitis | Phase 3 | Status: COMPLETED | Results posted: 2026-04-06